PMFG, CRWE, VPHM, LGND - Market Watch From PennyOmega.com!
(LGND, MJGCF, SPBC, GBLHF, QLGC) Stocks to Watch by CRWESelect.com
Ligand Pharmaceuticals Inc. (Nasdaq:LGND) announced that it has entered into a global licensing agreement with Chiva Pharmaceuticals, Inc. for Fablyn (lasofoxifene), a selective estrogen receptor modulator (SERM) that was approved in the EU in 2009 for the treatment of osteoporosis in post-menopausal women at increased risk of fracture.
(REXX, BGBV, FULT, CLNO, LGND) Stocks under Consideration by CRWESelect.com
NASDAQ:LCAV, ORFG.PK, NASDAQ:CVV, DLKM.OB, NASDAQ:LGND, - CRWESelect.com Stock Report! LCA-Vision, Orofino Gold Corp.
LCA-Vision Inc. (NASDAQ:LCAV) reported that 10,891 procedures were performed during the fourth quarter of 2010, compared with 11,718 procedures (68 vision centers) during the fourth quarter of 2009. Same-store procedures (54 vision centers) increased by 6% year-over-year from 10,241 procedures during the fourth quarter of 2009.
(MCHX, CHUX, ORFG, LGNDD, MSLP) Market News From PennyOmega.com.
MusclePharm Corporation (OTCBB:MSLP), will begin a clinical research program with the Metabolic and Body Composition Laboratory in the department of Health and Exercise Science at the University of Oklahoma to determine the effects of MusclePharm Assault(R) beginning in January 2011.